HL-085

· Shanghai Kechow Pharma, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for HL-085, covering 2023-05-31 to 2023-06-12. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of HL-085 Combined With Vemurafenib in BRAF V600E Patients With Non-small Cell Lung Cancer: a Phase II Clinical Study [Phase 2]

See pricing